Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Fulgent Genetics

Tracked across 2 events · 14 articles · First seen May 21, 2026 · Last active Jul 09, 2026

Sentiment
38
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 75
Tech
Impact: Fulgent Genetics announced positive interim results from its Phase 2 study of FID-007, which could significantly advance its therapeutic development business and potentially lead to a Phase 3 study. This positive data could increase investor confidence and its stock price.
May 21, 2026 · 8 articles
0 0
Business
Impact: Fulgent Genetics is the subject of the event, announcing its Q2 2026 earnings release date.
Jul 09, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Fulgent Genetics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.